Low-dose Fractionated Radiation (LDFRT) as a Chemopotentiator of Neoadjuvant Paclitaxel and Carboplatin for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: 5 Year Results Of A Prospective Phase II Trial

被引：0
|
作者：
Gleason, J. F. [1 ]
Kudrimoti, M. [1 ]
Van Meter, E. M. [1 ]
Mohiuddin, M. [2 ]
Regine, W. F. [3 ]
Valentino, J. [1 ]
Arnold, S. M. [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[3] Univ Maryland, Baltimore, MD 21201 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S502 / S503
页数：2
相关论文
共 50 条
  • [1] Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: Results of a new treatment paradigm
    Arnold, SM
    Regine, WF
    Ahmed, MM
    Valentino, J
    Spring, P
    Kudrimoti, M
    Kenady, D
    Desimone, P
    Mohiuddin, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1411 - 1417
  • [2] Low-dose fractionated radiation (LDFRT) as a potentiator of neoadjuvant paclitaxel (P) and carboplatin (C) in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Arnold, SM
    Kudrimoti, M
    Valentino, J
    Spring, P
    Ahmed, M
    Regine, W
    Given, C
    Kenady, D
    Mohiuddin, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S322 - S323
  • [3] Potentiating the effect of chemotherapy with low-dose fractionated radiation (LDFRT) in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Arnold, SM
    Kudrimoti, M
    Valentino, J
    Spring, P
    Ahmed, M
    Regine, W
    Kenady, D
    Given, C
    Mohiuddin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 237S - 237S
  • [4] Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial
    Gleason, John F., Jr.
    Kudrimoti, Mahesh
    Van Meter, Emily M.
    Mohiuddin, Mohammed
    Regine, William F.
    Valentino, Joseph
    Kenady, Daniel
    Arnold, Susanne M.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (01) : 35 - 42
  • [5] Low-dose fractionated radiation (LDFRT) plus paclitaxel (P) and carboplatin (CBCDA) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN): Two-year follow-up.
    Arnold, SM
    Kudrimoti, M
    Regine, W
    Valentino, J
    Spring, P
    Kenady, D
    Ahmed, M
    Mohiuddin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 511S - 511S
  • [6] Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
    Jeremic, B
    Shibamoto, Y
    Stanisavljevic, B
    Milojevic, L
    Milicic, B
    Nikolic, N
    RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) : 29 - 37
  • [7] Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Tanaka, Ryoko
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Togashi, Takafumi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1133 - 1141
  • [8] Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma
    Yushi Ueki
    Shusuke Ohshima
    Yusuke Yokoyama
    Takeshi Takahashi
    Ryusuke Shodo
    Keisuke Yamazaki
    Kohei Ohtaki
    Kohei Saijo
    Ryoko Tanaka
    Takafumi Togashi
    Yuichiro Sato
    Satoshi Takano
    Jo Omata
    Nao Takahashi
    Ryuichi Okabe
    Arata Horii
    International Journal of Clinical Oncology, 2024, 29 : 20 - 26
  • [9] Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma
    Ueki, Yushi
    Ohshima, Shusuke
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Saijo, Kohei
    Tanaka, Ryoko
    Togashi, Takafumi
    Sato, Yuichiro
    Takano, Satoshi
    Omata, Jo
    Takahashi, Nao
    Okabe, Ryuichi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (01) : 20 - 26
  • [10] A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Enokida, Tomohiro
    Ogawa, Takenori
    Homma, Akihiro
    Okami, Kenji
    Minami, Shujiro
    Nakanome, Ayako
    Shimizu, Yasushi
    Maki, Daisuke
    Ueda, Yuri
    Fujisawa, Takao
    Motegi, Atsushi
    Ohkoshi, Akira
    Taguchi, Jun
    Ebisumoto, Koji
    Nomura, Shogo
    Okano, Susumu
    Tahara, Makoto
    CANCER MEDICINE, 2020, 9 (05): : 1671 - 1682
12345